Search research articles
Contact Us
Filters
Showing results (41-50 of 87) with videos related to
Page
of 9
Sort By:
Clinicoeconomics and Outcomes Research : CEOR
|
August 29, 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
William Montgomery, Li Liu, Michael D Stensland, et al.
Neuropsychiatric Disease and Treatment
|
April 22, 2015
Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People's Republic of China
Jing Wu, Xiaoning He, Li Liu, et al.
Patient Preference and Adherence
|
July 3, 2013
Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
Diego Novick, William Montgomery, Zbigniew Kadziola, et al.
Patient Preference and Adherence
|
June 28, 2017
Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
Diego Novick, William Montgomery, Tamas Treuer, et al.
Neuropsychiatric Disease and Treatment
|
May 31, 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China
Wenyu Ye, William Montgomery, Zbigniew Kadziola, et al.
Patient Preference and Adherence
|
October 15, 2013
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
Jihyung Hong, Diego Novick, Tamás Treuer, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
|
December 15, 2015
Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder
Sheng Hu Wu, Ke Wang, Yun Chen, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
|
March 27, 2015
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
Jihyung Hong, Diego Novick, William Montgomery, et al.
Patient Preference and Adherence
|
November 4, 2015
Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
Jihyung Hong, Diego Novick, William Montgomery, et al.
BMC Psychiatry
|
November 1, 2014
Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia
Jihyung Hong, Diego Novick, Tamás Treuer, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 87) with videos related to
Sort By:
Page
of 9
Clinicoeconomics and Outcomes Research : CEOR
|
August 29, 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
William Montgomery, Li Liu, Michael D Stensland, et al.
Neuropsychiatric Disease and Treatment
|
April 22, 2015
Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People's Republic of China
Jing Wu, Xiaoning He, Li Liu, et al.
Patient Preference and Adherence
|
July 3, 2013
Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
Diego Novick, William Montgomery, Zbigniew Kadziola, et al.
Patient Preference and Adherence
|
June 28, 2017
Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
Diego Novick, William Montgomery, Tamas Treuer, et al.
Neuropsychiatric Disease and Treatment
|
May 31, 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China
Wenyu Ye, William Montgomery, Zbigniew Kadziola, et al.
Patient Preference and Adherence
|
October 15, 2013
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
Jihyung Hong, Diego Novick, Tamás Treuer, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
|
December 15, 2015
Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder
Sheng Hu Wu, Ke Wang, Yun Chen, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
|
March 27, 2015
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
Jihyung Hong, Diego Novick, William Montgomery, et al.
Patient Preference and Adherence
|
November 4, 2015
Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
Jihyung Hong, Diego Novick, William Montgomery, et al.
BMC Psychiatry
|
November 1, 2014
Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia
Jihyung Hong, Diego Novick, Tamás Treuer, et al.
Page
of 9